美国专利US20010007059A1 Local drug delivery injection catheter daryush mirzaee

专利PDF首页>>美国专利

专利附录

专利说明

权利要求

类似技术

同族专利

引用文献

法律状态

优先权

专利摘要:
A catheter for injecting medication to a specific point within a patient comprises a drug delivery lumen extending from a proximal end of the catheter to an injection port. The catheter comprises a mechanism for angularly pushing the injection port outwardly away from the body of the catheter into an artery wall so that medication can be injected directly into the artery wall.
公开号:US20010007059A1
申请号:US09/794,791
申请日:2001-02-27
公开日:2001-07-05
发明作者:Daryush Mirzaee
申请人:Advanced Cardiocasvular Systems Inc；
IPC主号:A61M25-10

专利说明:
[0001] This invention pertains to a catheter for delivering a drug to a specific location within a patient's artery. [0001]
[0002] It is known in the art to provide catheters for delivering drugs directly into the walls of a patient's artery. An example of such a catheter is described in U.S. Pat. No. 5,746,716, issued to Vigil et al. Vigil's catheter 1 includes a set of injectors 2 for injecting medication into an artery wall 3 (FIG. 1). Injectors 2 are mounted on a balloon 4 which is inflated when it is desired to push injectors 2 into artery wall 3. Unfortunately, injectors 2 extend in a direction perpendicular to the axis of catheter 1. Thus, when catheter 1 is inserted or withdrawn from the patient's vascular system, there is a danger that injectors 2 will drag along and injure artery wall 3. [0002]
[0003] What is needed is an improved catheter which permits delivery of a drug into the walls of an artery where the drug is believed to be most effective. [0003]
[0004] What is also needed is a catheter with injectors which will not drag across the artery walls when the catheter is inserted or withdrawn from a patient. [0004] SUMMARY
[0005] A catheter in accordance with an embodiment of the invention comprises an injection port at or near the distal end thereof and a mechanism for directing the injection port angularly away from the central axis of the catheter and into the artery wall. (An injection port is a structure used for introducing medication or other material into a patient. The injection port typically is a hollow needle.) In one embodiment, the catheter includes a guide wire lumen for receiving a guide wire that enables a physician to direct the catheter to a desired location within the patient's vascular system. Also, in one embodiment, the catheter includes a plurality of needles, each of which may be manipulated at an angle outwardly from the central longitudinal axis of the catheter so that the needles can inject a drug or medication into the surrounding tissue. Prior to deployment of the needles, the needles are retained such that they lie substantially parallel to the longitudinal axis of the catheter. [0005]
[0006] In one embodiment, a balloon is provided towards the distal end of the catheter for pushing the needles outwardly into the artery wall. In another embodiment, other mechanical means are provided for pushing the needles outwardly. [0006]
[0007] These and other features of the invention are described below. [0007] BRIEF DESCRIPTION OF THE DRAWINGS
[0008] FIG. 1 illustrates a prior art catheter for injecting medication into a patient's artery walls. [0008]
[0009] FIG. 2 illustrates in cross section a catheter constructed in accordance with the invention comprising needles for injecting medication into an artery wall. [0009]
[0010] FIG. 3 illustrates in cross section the catheter of FIG. 2 in which the needles are extended outwardly for injecting medication into the artery wall. [0010]
[0011] FIG. 3′ illustrates an enlarged portion of the catheter of FIG. 3. [0011]
[0012] FIG. 3A illustrates in cross section the catheter of FIGS. 2 and 3 along lines A-A. [0012]
[0013] FIG. 3B illustrates in cross section an alternative embodiment of a catheter along lines A-A in which a stiffening mandrel is provided external to two of the catheter tubes. [0013]
[0014] FIG. 3C illustrates a cut formed in a tube to accommodate placement of a needle. [0014]
[0015] FIG. 3D illustrates another cut formed in a tube to accommodate placement of a needle. [0015]
[0016] FIG. 4 illustrates another embodiment of a catheter including a balloon for pushing needles from the catheter outwardly into the artery wall. [0016]
[0017] FIGS. 4A, 4B and [0017] 4C illustrate in cross section the catheter of FIG. 4 along lines A-A, B-B and C-C, respectively.
[0018] FIG. 4D illustrates in cross section an alternative balloon used in conjunction with another embodiment of a catheter in accordance with the invention. [0018]
[0019] FIG. 4E illustrates another embodiment of a catheter including a balloon for pushing needles from the catheter outwardly into the artery wall. [0019]
[0020] FIG. 5 illustrates in cross section a modified embodiment of the catheter of FIG. 4 including a short balloon length with a steep proximal balloon wall. [0020]
[0021] FIG. 6 illustrates the distal end of a catheter including a helical balloon in accordance with another embodiment of the invention. [0021]
[0022] FIG. 7 illustrates a catheter in accordance with the invention in conjunction with a sheath. [0022] DETAILED DESCRIPTION
[0023] Referring to FIGS. 2, 3 and [0023] 3′, a catheter 10 in accordance with an embodiment of the invention includes a proximal end 10 p, a distal end 10 d and a centrally located guide wire tube 29 having a lumen 12 for receiving a guide wire 14. Thus, prior to use, an attending physician can route guide wire 14 into the patient and insert catheter 10 over the guide wire to a desired location within the patient's vascular system. Once catheter 10 is in place, guide wire 14 extends through lumen 12 and out of a guide wire control port 16.
[0024] Also within catheter [0024] 10 is a drug delivery port 18 for receiving a drug to be injected into the patient. Drug delivery port 18 is connected to a drug delivery lumens 22 a, 22 b. (In one embodiment, not shown, lumens 22 a and 22 b can merge into a single lumen concentrically surrounding guide wire tube 29.)
[0025] Although FIGS. 2, 3, and [0025] 3′ illustrate two lumens 22 a, 22 b, other numbers of lumens for delivering drugs can also be used, e.g., between two and four lumens. However, the invention is not limited by the exact number of drug delivery lumens 22.
[0026] A shrink tube [0026] 24 approximately 1 to 6 cm from distal end 10 d of catheter 10 binds tubes 27 a, 27 b (surrounding lumens 22 a, 22 b) together. Shrink tube 24 is affixed to tube 27 a, 27 b, but surrounds and can slide along guide wire tube 29. At a distance D1 from shrink tube 24, tubes 27 a, 27 b are sliced around a circumferential portion of approximately 180°, and hollow needles 26 a, 26 b, are inserted into lumens 22 a, 22 b respectively. (The slice formed in tubes 27 a and 27 b can have different shapes. FIGS. 3C and 3D illustrate two embodiments of slices 31 a, 31 b that can be formed in tubes 27 a and 27 b to accommodate needle placement. The slices 31 a, 31 b help create a preferential bending position for tubes 27 a and 27 b and are sized to facilitate needle placement.) Needles 26 a, 26 b can be held in place within lumens 22 a, 22 b, for example, by an appropriate adhesive (e.g. cynoacrylate). Tubes 27 a, 27 b continue distally of needles 26 a, 26 b. Tubes 27 a, 27 b terminate at distal end 10 d of catheter 10, and are bound together and to guide wire tube 29 with second shrink tube 28. (Shrink tube 28 cannot move relative to tube 29.) Needles 26 a, 26 b are typically located half way between shrink tube 28 and shrink tube 24. The very ends 27 a′, 27 b′ of tubes 27 a, 27 b may be open or sealed.
[0027] In one embodiment, shrink tubes [0027] 24 and 28 are located at preferential bending positions of tubes 27 a and 27 b. Because tubes 27 a, 27 b are not bound to tube 29 along the entire length of catheter 10, this permits relative motion of portions of tubes 27 a, 27 b and tube 29. (As explained below, during use, moving tubes 27 a and 27 b relative to tube 29 pushes needles 26 outwardly into the artery wall or inwardly towards guide wire tube 29.) The fact that tubes 27 a, 27 b are not rigidly bound to tube 29 by shrink tube 24 facilitates bending of the tubes 27 a, 27 b.
[0028] Referring to FIG. 3, in accordance with the first embodiment of the invention, after catheter [0028] 10 is in its proper position within the patient's vascular system, a physician extends needles 26 a, 26 b outwardly (in directions A and B, respectively) by sliding drug delivery port 18 in a forward direction (see arrow C) relative to guide wire control port 16.
[0029] A portion of catheter [0029] 10 is shown in greater detail in FIG. 3′. The movement of drug delivery port 18 relative to guide wire control port 16 causes a first body portion of catheter 10 comprising tubes 27 a and 27 b to move relative to a second body portion comprising tube 29. Portions P1, P2 and P3 of tube 27 a and portions P4, P5 and P6 of tube 27 b act as hinges, permitting needles 26 a, 26 b to move outwardly. In this way, needles 26 a, 26 b are pushed away at an angle α from the main axis of catheter 10 and into the artery wall of the patient.
[0030] In other words, during insertion and placement of catheter [0030] 10, needles 26 a, 26 b and the portions of tubes 27 a, 27 b connected to needles 26 a, 26 b lie substantially parallel to guide wire 14 (i.e., α=0°). When the needles 26 a, 26 b are deployed, portions P1, P2 serve as axes of rotation for the needles 26 a, 26 b and the portions of tubes 27 a, 27 b connected to needles 26 a, 26 b. Needles 26 a, 26 b are rotationally pushed away such that portions of tubes 27 a, 27 b connected to needles 26 a, 26 b thus form an angle α>0°. When deployed, needles 26 a, 26 b extend outwards from the main body of catheter 10 by a distance D4, thereby contacting the artery wall.
[0031] The attending physician can then inject medication through drug delivery lumens [0031] 22 a, 22 b and needles 26 a, 26 b into the wall of the patient's artery. Such medication can be, for example, an anti-inflammatory, anti-restenotic, or anti-thrombotic medication. Thereafter, the physician can retract needles 26 in directions D and E by pulling drug delivery port 18 in a direction F relative to guide wire control port 16. Catheter 10 can then be retracted from the patient.
[0032] In one embodiment, needles [0032] 26 a, 26 b are stainless steel, have an inner diameter of 0.002″ to 0.010″ and an outer diameter of 0.005″ to 0.014″, extend a distance D2 (FIG. 3) of 1 to 3 mm outside of tubes 27 a, 27 b, and have a total length of 3 to 8 mm. However, other needle sizes can also be used. Catheter 10 can be designed such that distance D4 is customized to facilitate better deployment into different size arteries, e.g. coronary or peripheral. Needles 26 a, 26 b can be blunt, as shown in FIG. 3, or sharp.
[0033] The distance D[0033] 3 (FIG. 2) between shrink tube 24 and the point where needles 26 a, 26 b exit from tubes 27 a, 27 b is between 2 to 10 mm. Distances D2 (FIG. 3) and D3 (FIG. 2) are chosen based on the caliber of the artery in which catheter 10 is to be used. The greater the artery caliber, the greater the total distance D2 plus D3. This is done to ensure that needles 26 reach the artery wall when they are outwardly extended.
[0034] In one embodiment, a catheter in accordance with the invention can be the length L[0034] 1 (FIG. 2) of conventional balloon dilatation catheters, e.g., 40 to 200 cm. The sliding portion of catheter 10 can have a distance L2 (FIG. 2) between 35 and 195 cm. Shrink tube 28 can be a distance D4 (FIG. 2) between 2 and 30 mm from the distal end of catheter 10. However, other lengths and distances can also be used.
[0035] Stiffening mandrels [0035] 30 a, 30 b can be provided within lumens 22 a, 22 b of tubes 27 a, 27 b as shown in FIGS. 2, 3, 3′, 3A and 3B. In one embodiment, the distal ends of mandrels 30 a, 30 b (e.g. the distal 1 to 20 mm) can be flatter than the proximal ends of mandrels 30 a, 30 b. Optionally, notches can be formed in stiffening mandrels 30 a and 30 b to facilitate preferential bending at the location of the notches. In another embodiment, the mandrels are a shape memory alloy such as nitinol having a preferential bend formed therein. In lieu of placing mandrels 30 a, 30 b within lumens 22 a, 22 b, stiffening mandrels 30 a, 30 b can be affixed to the exterior of tubes 27 a, 27 b as shown in FIG. 3B.
[0036] The mandrels are typically 0.003″ to 008″ wide. If the mandrels are not within lumens [0036] 22 a and 22 b those lumens are typically 0.006″ to 0.016″ wide (i.e. an inner diameter of 0.006″ to 0.016″). If the mandrels are within lumens 22 a and 22 b, lumens 22 a and 22 b are typically 0.009″ to 0.020″ wide.
[0037] Guide wire lumen [0037] 12 is typically about 0.010″ to 0.040″ wide depending upon where the catheter is to be used. For coronary artery applications, lumen 12 is about 0.012″ to 0.018″ wide. For peripheral arteries, lumen 12 can be as wide as 0.040″.
[0038] FIG. 4 illustrates an alternative embodiment of the invention in which a catheter [0038] 10′ includes a balloon 32 coupled to a balloon inflation lumen 34. Balloon 32 can be constructed in the same manner as a PTCA (percutaneous transluminal coronary angioplasty) balloon. Alternatively, balloon 32 can be doughnut shaped.
[0039] Operation of catheter [0039] 10′ is similar to that of catheter 10 shown in FIGS. 2 and 3. A physician first inserts guide wire 14 into the patient, and then advances catheter 10′ over guide wire 14 until hollow needles 26 a, 26 b are at an appropriate location. When it is desired to insert needles 26 a, 26 b into the patient's artery wall, a physician injects inflation fluid through a balloon inflation port 35 at the proximal end 10 p′ of catheter 10′ through balloon inflation lumen 34 into balloon 32. Balloon 32 then expands and pushes needles 26 a, 26 b outwardly into the artery wall. In other words, needles 26 a, 26 b are rotated outwardly away from the longitudinal axis of catheter 10′ (Arrow AC in FIG. 4 is parallel to the longitudinal catheter axis. Arrow AN is the longitudinal needle axis.) During this process, the points adjacent where tube 27 a, 27 b contact shrink tube 24 act as a hinge. Drugs can then be injected through drug delivery port 18, single drug delivery lumen 20, lumens 22 a, 22 b and needles 26 a, 26 b. Thereafter, needles 26 a, 26 b are retracted by deflating balloon 32 (i.e., by withdrawing inflation fluid from balloon 32 via balloon inflation lumen 34 and balloon inflation port 35). Catheter 10′ is then withdrawn from the patient. Balloon 32 is typically affixed to tubes 27 a, 27 b at points 32 a, 32 b with an adhesive such as epoxy. (Alternatively, balloon 32 can be affixed to tubes 27 a, 27 b by other methods, such as welding.) Thus, when balloon 32 is deflated and contracts, it rotationally pulls needles 26 inwardly and substantially parallel to the longitudinal catheter axis AC so that needles 26 will not drag along the artery wall when the catheter 10′ is retracted. (In other words, the longitudinal needle axes AN are rotated to be substantially parallel to the longitudinal catheter axis AC.) Although not shown in FIG. 4, tubes 27 a, 27 b can include mandrels 30 a, 30 b to enhance their stiffness, as described above with respect to FIGS. 2, 3, 3A, and 3B.
[0040] Balloon [0040] 32 can be shaped like a conventional dilatation catheter balloon (e.g. the same length and profile). Alternatively, balloon 32 may be shorter than a conventional dilatation catheter. In one embodiment, balloon 32 has a length L3 between 3 and 10 mm.
[0041] As can be seen, in the embodiment of FIG. 4, the proximal portion [0041] 10 p′ of catheter 10′ includes a single drug delivery lumen 20 which divides into two (or more) lumens 22 a, 22 b. In the embodiment shown in FIG. 4E, the distal end 10 d′ of catheter 10′ which includes shrink tube 28 (as shown in FIG. 4), is not included.
[0042] FIGS. 4A, 4B, and [0042] 4C illustrate in cross section portions of catheter 10′ along lines A-A, B-B, and C-C, respectively. FIG. 4A shows single drug delivery lumen 20, balloon inflation lumen 34, guide wire lumen 12, and guide wire 14. FIG. 4B shows a cross sectional portion of catheter 10′ after single drug delivery lumen 20 has divided into two drug delivery lumens 22 a, 22 b surrounded by tubes 27 a, 27 b. Finally, FIG. 4C illustrates a cross-sectional view of catheter 10′ along line C-C, with inflated balloon 32 pushing tubes 27 a, 27 b in an angle away from the longitudinal axis of catheter 10′. While FIGS. 4, 4A, 4B, and 4C illustrate a single drug delivery lumens 20, in other embodiments a single drug delivery lumens 20 is not used, and lumens 22 a, 22 b extend to drug delivery port 18.
[0043] As with the embodiment of FIG. 3, the length of the portion of tubes [0043] 27 a, 27 b distal to shrink tube 24 can vary. In one embodiment, when needles 26 a, 26 b are in their extended position, they only extend a short distance past the top of balloon 32. In other embodiments, needles 26 a, 26 b can extend a longer distance past the top of balloon 32.
[0044] FIG. 5 illustrates a catheter similar to that of FIG. 4 except that a balloon [0044] 32 has a short length. When balloon 32 is inflated, proximal end 32′ of balloon 32 forms a steep step. Needles 26 a, 26 b extend only a very short distance beyond surface 32″ of balloon 32, and are deployed at a near-perpendicular angle with respect to the longitudinal catheter axis in FIG. 5. However, when balloon 32 is deflated, needles 26 a, 26 b are brought to an angle parallel or substantially parallel to the longitudinal catheter axis.
[0045] In FIGS. 4, 4E, and [0045] 5, balloon 32 is substantially cylindrical. However, FIG. 4D illustrates in cross section along lines C-C an embodiment of a catheter comprising a balloon 33 which, when inflated, has a clover-like cross section including large wide sections 33 a and narrow sections 33 b. Narrow sections 33 b advantageously permit blood to perfuse past balloon 33 when the catheter is being used and balloon 33 is inflated.
[0046] FIG. 4D shows four tubes [0046] 27 instead of two tubes 27 a, 27 b. However, as mentioned above, different numbers of tubes 27 can be used.
[0047] In lieu of the balloon shapes shown in FIGS. 4, 5, and [0047] 4D, a helical balloon 35 as shown in FIG. 6 can be employed. The helical shape of balloon 35 facilitates blood perfusion past balloon 35 during use.
[0048] In the above embodiments, the catheter in accordance with the present invention may be used in conjunction with a thin cylindrical sheath [0048] 40. FIG. 7 shows catheter 10 of FIG. 2 used in conjunction with a sheath 40 that may be used to surround a portion of catheter 10 to cover needles 26 a, 26 b (and balloon 32, 33, or 36, in the case of an embodiment including a balloon 32, 33, or 36). Sheath 40 keeps needles 26 a, 26 b close to the catheter body, thereby ensuring a low profile, and ensuring that needles 26 a, 26 b stay aligned with the longitudinal axis of catheter 10. When catheter 10 is inserted into the patient's blood vessel at the desired position, sheath 40 extends proximally out of the patient's blood vessel so that the physician can manipulate the sheath 40. A sheath removal handle 42 is affixed to the proximal end of sheath 40. Sheath 40 may be pulled back once the catheter 10 is at a desired position before extending needles 26 a, 26 b and delivering the drug or medication. After use, sheath 40 can be advanced in the distal direction to again cover needles 26 a, 26 b prior to retracting the catheter 10.
[0049] In the above-described embodiments, various structures in the catheter [0049] 10 can be formed from radiopaque materials so that the position of catheter 10 may be easily observed during use. For example, the needles 26 a, 26 b may be radiopaque. This can be accomplished, e.g., by plating needles 26 a, 26 b with or constructing needles 26 a, 26 b from a radiopaque material such as titanium or tungsten. Alternatively, radiopaque materials may be placed on the catheter near needles 26 a, 26 b or preferential bending points P1 to P6. Alternatively, radiopaque materials may be placed on the balloon 32, 33, 36.
[0050] The above-described embodiment incorporates shrink tubing, e.g., shrink tubes [0050] 24 and 28, to hold various tubes of the catheter 10 together. In lieu of, or in addition to such shrink tubing, the various catheter tubes can be held together by other means, e.g., adhesive heat fusing. Alternatively, the tubes can be coextruded together and then separated by cutting at those locations where the tubes must be permitted to slide relative to one another.
[0051] A catheter [0051] 10 in accordance with the invention has numerous advantages:
[0052] 1) The catheter [0052] 10 permits blood perfusion (i.e. blood flow around the catheter 10), enabling the catheter 10 to remain within the blood vessel for as long as deemed necessary by the attending physician. This is because the catheter 10 does not block the entire artery lumen even when needles 26 a, 26 b are extended outwardly.
[0053] 2) The catheter [0053] 10 is typically very flexible, permitting access to distal, tortuous arteries. The reason for this is that the stiff portion of the catheter 10 (the portion of the length along which needles 26 a, 26 b extend) is very small.
[0054] 3) While the catheter is being positioned, needles [0054] 26 a, 26 b lie in the axial direction of catheter 10 substantially parallel to the longitudinal axis AC of catheter 10, thereby minimizing the profile of the catheter 10 and minimizing the chance of injury to the artery.
[0055] While the invention has been described with regard to specific embodiments, those skilled in the art will recognize that changes can be made in form and detail without departing from the spirit and scope of the invention. For example, the material from which the catheter is made can be any extruded polymer or metal, including shape memory metals or a combination thereof. Also, although the embodiments of FIGS. [0055] 2 to 7 contain a guide wire lumen 12, and are used in conjunction with a guide wire 14, other embodiments are not used in conjunction with a guide wire 14. In alternative embodiments, a guide wire 14 is not used, and the space which would otherwise be occupied by guide wire lumen 12 is sealed.
[0056] In yet another embodiment, guide wire lumen [0056] 12 does not extend the entire length of catheter 10. Instead, guide wire lumen 12 terminates between 1 and 35 cm from distal end 10 d of catheter 10, and guide wire 14 extends through only the distal 1 to 35 cm of catheter 10. This facilitates rapid exchange of catheter 10 over guide wire 14.
[0057] In yet another embodiment, the catheter can contain other lumens for performing other functions. For example, one can place balloons proximal to shrink tube [0057] 24 and distal to shrink tube 28 to prevent medication from diffusing away from the injection site.
[0058] Needles [0058] 26 a, 26 b can extend greater or lesser distances D2 past tubes 27 a, 27 b. Also, in some embodiments, tubes 27 a, 27 b and needles 26 a, 26 b can be extended at angles closer to or further from right angles than illustrated in FIGS. 3 to 6. The angle at which tubes 27 a, 27 b and needles 26 a, 26 b are extended is typically between 45 and 100°.
[0059] In some embodiments, the catheter is used in vessels other than arteries. Accordingly, all such changes come within the invention. [0059]

权利要求:
Claims (20)
[1" id="US-20010007059-A1-CLM-00001] 1. A catheter for delivering a drug to a location within a patient, comprising:
a tube extending from a proximal end to a distal end along an axis and having a first lumen for receiving said drug, said first lumen extending from the proximal end of said tube to an injection port; and
a mechanism for angularly pushing said injection port away from the axis of the tube.
[2" id="US-20010007059-A1-CLM-00002] 2. Catheter of
claim 1 wherein said injection port comprises a needle.
[3" id="US-20010007059-A1-CLM-00003] 3. Catheter of
claim 1 wherein the tube includes a second balloon lumen and said mechanism comprises a balloon coupled to the balloon lumen, inflation of the balloon pushing said injection port outwardly away from said tube.
[4" id="US-20010007059-A1-CLM-00004] 4. Catheter of
claim 1 wherein said tube comprises a first body portion which slides relative to a second body portion, said injection port being mechanically coupled to both said first and second body portions such that when said first body portion is moved in a first direction relative to said second body portion, said injection port is pushed outwardly toward said artery wall.
[5" id="US-20010007059-A1-CLM-00005] 5. Catheter of
claim 4 wherein said first body portion comprises a guide wire tube and said second body portion comprises a drug delivery tube, said guide wire tube and said drug delivery tube extending out of a patient during use so that said guide wire tube and drug delivery tube can be manipulated by a physician.
[6" id="US-20010007059-A1-CLM-00006] 6. Catheter of
claim 2 wherein said injection port is radiopaque.
[7" id="US-20010007059-A1-CLM-00007] 7. Catheter of
claim 1 wherein said mechanism comprises a balloon coupled to a balloon lumen, and a radiopaque marker is provided on said balloon.
[8" id="US-20010007059-A1-CLM-00008] 8. Catheter of
claim 1 wherein the tube includes a second lumen called a balloon lumen and said mechanism comprises a balloon coupled to the balloon lumen, and a radiopaque marker is formed on said catheter proximate to said balloon.
[9" id="US-20010007059-A1-CLM-00009] 9. Catheter of
claim 1 wherein radiopaque marker is provided on said tube at a preferential bending point where said injection port bends away from said axis.
[10" id="US-20010007059-A1-CLM-00010] 10. Catheter of
claim 1 further comprising a stiffening mandrel extending through said drug delivery tube.
[11" id="US-20010007059-A1-CLM-00011] 11. Catheter of
claim 1 wherein said first lumen extends within a drug delivering tube, and a stiffening mandrel extends along the exterior of said drug delivery tube.
[12" id="US-20010007059-A1-CLM-00012] 12. Catheter of
claim 1 further comprising a sheath surrounding said tube to insure that said injection port does not drag along a patient's artery wall when said tube is being positioned within the patient.
[13" id="US-20010007059-A1-CLM-00013] 13. Catheter of
claim 1 wherein said mechanism is a helical-shaped balloon.
[14" id="US-20010007059-A1-CLM-00014] 14. Catheter of
claim 1 wherein said mechanism is a balloon having wide and narrow regions to permit blood to perfuse past said balloon when said balloon is inflated.
[15" id="US-20010007059-A1-CLM-00015] 15. A catheter for delivering a drug to a location within a patient comprising:
a tube extending from a proximal end to a distal end along an axis and having a first lumen for receiving said drug, said first lumen extending from the proximal end of said tube to an injection port; and
a mechanism for rotating said injection port away from the axis of the catheter.
[16" id="US-20010007059-A1-CLM-00016] 16. Method for delivering medication to a patient comprising the steps of:
inserting a catheter into a patient, said catheter comprising a catheter body, a drug delivery lumen within the catheter body, and an injection port in communication with said drug delivery lumen;
angularly extending the injection port away from the catheter axis toward or into the patient's artery wall; and
injecting medication into the patient through the drug delivery lumen and said injection port.
[17" id="US-20010007059-A1-CLM-00017] 17. Method of
claim 16 wherein said injection port is a needle.
[18" id="US-20010007059-A1-CLM-00018] 18. Method of
claim 16 further comprising the steps of:
moving said injection port toward an angle parallel with the axis of said catheter after said step of injecting; and
retracting said catheter.
[19" id="US-20010007059-A1-CLM-00019] 19. Method of
claim 16 wherein said step of extending the injection port at an angle away from the catheter axis is performed by inflating a balloon.
[20" id="US-20010007059-A1-CLM-00020] 20. Method of
claim 16 wherein said step of extending the injection port at an angle away from the catheter axis is performed by moving a first portion of the proximal end of said catheter relative to a second portion of the proximal end of said catheter.

类似技术:

公开号 | 公开日 | 专利标题

US6283947B1|2001-09-04|Local drug delivery injection catheter

EP0891171B1|2004-11-03|Rapid exchange delivery cathether system

US5267958A|1993-12-07|Exchange catheter having exterior guide wire loops

US6605062B1|2003-08-12|Catheter for guidewire support or exchange

US6780199B2|2004-08-24|Enhanced stent delivery system

EP0564894B1|1999-06-16|Rapid exchange catheter system

JP2956966B2|1999-10-04|Catheter assembly and stent delivery system

JP5666912B2|2015-02-12|Drug delivery catheter having a radially expandable centering support member

US5439445A|1995-08-08|Support catheter assembly

JP2918502B2|1999-07-12|Balloon catheter for stent insertion

US5554114A|1996-09-10|Infusion device with preformed shape

US5449362A|1995-09-12|Guiding catheter exchange device

US6447501B1|2002-09-10|Enhanced stent delivery system

EP0515119A1|1992-11-25|Intravascular device

AU2008203188A1|2008-08-14|Catheter with disruptable guidewire channel

EP1368086A2|2003-12-10|Vascular catheter guide wire carrier

CA2109095A1|1992-10-23|Helical balloon perfusion angioplasty catheter

JP2011505918A5|2013-09-12|

JP6537200B2|2019-07-03|Occlusal bypass device and method with variable flexibility for bypassing an intravascular occlusion

EP3052176B1|2019-05-15|Radial and trans-endocardial delivery catheter

US5984946A|1999-11-16|Diagnostic and guiding catheter

US8366664B2|2013-02-05|Agent delivery catheter having articulating arms

US7273486B2|2007-09-25|Catheter with a convertible proximal catheter shaft

CN212491101U|2021-02-09|Drug-coated balloon catheter

WO2006046244A2|2006-05-04|Method and apparatus for diverting a guidewire through a bifurcated passageway

同族专利:

公开号 | 公开日

US6283947B1|2001-09-04|

US6689099B2|2004-02-10|

引用文献:

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

US20060206062A1|2005-03-09|2006-09-14|Wendy Naimark|Rotatable multi-port therapeutic delivery device|

US20070250035A1|2006-04-19|2007-10-25|El-Nounou Fozan O|Devices and methods for intravascular drug delivery|

US20090118700A1|2007-11-07|2009-05-07|Callas Peter L|Method for treating coronary vessels|

EP2065069A1|2007-11-29|2009-06-03|National University of Ireland Galway|A Catheter based Medical Device and Method for Delivery of a Therapeutic Agent|

US8216209B2|2007-05-31|2012-07-10|Abbott Cardiovascular Systems Inc.|Method and apparatus for delivering an agent to a kidney|

US20140128805A1|2009-07-20|2014-05-08|Ams Research Corporation|Devices, systems, and methods for delivering fluid to tissue|

US9144509B2|2007-05-31|2015-09-29|Abbott Cardiovascular Systems Inc.|Method and apparatus for delivering an agent to a kidney|

US9149610B2|2007-05-31|2015-10-06|Abbott Cardiovascular Systems Inc.|Method and apparatus for improving delivery of an agent to a kidney|

US9364586B2|2007-05-31|2016-06-14|Abbott Cardiovascular Systems Inc.|Method and apparatus for improving delivery of an agent to a kidney|

WO2016115102A1|2015-01-13|2016-07-21|Pigott John P|Intravascular catheter having an expandable portion|

US20170266411A1|2016-03-16|2017-09-21|Krishna Rocha-Singh, M.D.|Apparatus and method for promoting angiogenesis in ischemic tissue|

US10315014B2|2013-07-15|2019-06-11|John P. Pigott|Balloon catheter having a retractable sheath and locking mechanism with balloon recapture element|

US10463387B2|2011-09-13|2019-11-05|John P. Pigott|Intravascular catheter having an expandable incising portion for incising atherosclerotic material located in a blood vessel|

US10485572B2|2011-09-13|2019-11-26|John P. Pigott|Intravascular catheter having an expandable incising portion|

US10603069B2|2015-01-13|2020-03-31|John P. Pigott|Intravascular catheter balloon device having a tool for atherectomy or an incising portion for atheromatous plaque scoring|

US10610255B2|2011-09-13|2020-04-07|John P. Pigott|Intravascular catheter having an expandable incising portion and medication delivery system|

US10610669B2|2016-03-16|2020-04-07|Krishna Rocha-Singh, M.D.|Apparatus and method for promoting angiogenesis in ischemic tissue|

US10828471B2|2013-07-15|2020-11-10|John P. Pigott|Balloon catheter having a retractable sheath|

US11154693B2|2013-07-15|2021-10-26|John P. Pigott|Balloon catheter having a retractable sheath|

US11202892B2|2013-07-15|2021-12-21|John P. Pigott|Balloon catheter having a retractable sheath|US3930761A|1972-12-19|1976-01-06|The Boots Company, Ltd.|Portable and manually operable peristaltic pump|

US4578061A|1980-10-28|1986-03-25|Lemelson Jerome H|Injection catheter and method|

US4465072A|1983-02-22|1984-08-14|Taheri Syde A|Needle catheter|

CA1294119C|1985-11-04|1992-01-14|The Procter & Gamble Company|Absorbent article having an expanding overwrap|

US4655746A|1985-12-02|1987-04-07|Target Therapeutics|Catheter device|

US4878904A|1987-06-16|1989-11-07|Callaway James J|Intravenous needle and holder assembly|

HU212760B|1989-06-20|1997-02-28|Denes|Method and device for the apportion of chemical materials into the vein wall|

US5049138A|1989-11-13|1991-09-17|Boston Scientific Corporation|Catheter with dissolvable tip|

EP0533816B1|1990-06-15|1995-06-14|Cortrak Medical, Inc.|Drug delivery apparatus|

CA2074304C|1991-08-02|1996-11-26|Cyril J. Schweich, Jr.|Drug delivery catheter|

IT1251532B|1991-10-31|1995-05-16|Pasquale Mastronardi|NEEDLE CANNULA PROVIDED WITH SAFETY DEVICE|

US5538504A|1992-07-14|1996-07-23|Scimed Life Systems, Inc.|Intra-extravascular drug delivery catheter and method|

US5380307A|1992-09-30|1995-01-10|Target Therapeutics, Inc.|Catheter with atraumatic drug delivery tip|

DE4235506A1|1992-10-21|1994-04-28|Bavaria Med Tech|Drug injection catheter|

US5261889A|1992-11-24|1993-11-16|Boston Scientific Corporation|Injection therapy catheter|

US5279565A|1993-02-03|1994-01-18|Localmed, Inc.|Intravascular treatment apparatus and method|

US5523092A|1993-04-14|1996-06-04|Emory University|Device for local drug delivery and methods for using the same|

US5415637A|1993-04-14|1995-05-16|Advanced Cardiovascular Systems, Inc.|Temporary stenting catheter with drug delivery capabilities|

US5716410A|1993-04-30|1998-02-10|Scimed Life Systems, Inc.|Temporary stent and method of use|

US5462523A|1993-05-18|1995-10-31|Target Therapeutics, Inc.|Drug delivery system|

US5342295A|1993-09-24|1994-08-30|Cardiac Pathways Corporation|Catheter assembly, catheter and multi-port introducer for use therewith|

US5505698A|1993-10-29|1996-04-09|Medtronic, Inc.|Cardioplegia catheter with elongated cuff|

US5378230A|1993-11-01|1995-01-03|Mahurkar; Sakharam D.|Triple-lumen critical care catheter|

JP3403233B2|1994-01-20|2003-05-06|テルモ株式会社|Balloon catheter|

DE4408108A1|1994-03-10|1995-09-14|Bavaria Med Tech|Catheter for injecting a fluid or a drug|

US5531679A|1994-03-14|1996-07-02|Schulman; Joseph H.|Fluidic infusion system for catheter or probe|

US5464395A|1994-04-05|1995-11-07|Faxon; David P.|Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway|

US5460618A|1994-06-20|1995-10-24|Minimed Inc.|Side slit catheter|

US5465072A|1994-08-05|1995-11-07|Linear Technology Corporation|Tunable operational transcondunctance amplifier having high linearity|

US5891108A|1994-09-12|1999-04-06|Cordis Corporation|Drug delivery stent|

US5836940A|1994-10-25|1998-11-17|Latis, Inc.|Photoacoustic drug delivery|

US5626562A|1994-11-28|1997-05-06|Devices For Vascular Intervention|Drug delivery catheter|

US5537713A|1994-12-19|1996-07-23|Docteur; Terrence R.|Pivot bushing|

US5569197A|1994-12-21|1996-10-29|Schneider Inc|Drug delivery guidewire|

JP3713048B2|1994-12-27|2005-11-02|アドバンスト・カーディオバスキュラー・システムズ・インコーポレイテッド|Catheter with reinforced oval cross section|

US5562630A|1995-01-18|1996-10-08|Nichols; Charlotte A.|Apparatus and method for insertion of blood vessel catheters without blood loss|

US5569198A|1995-01-23|1996-10-29|Cortrak Medical Inc.|Microporous catheter|

US5749845A|1995-01-25|1998-05-12|Iotek, Inc.|Delivering an agent to an organ|

US5702372A|1995-02-08|1997-12-30|Medtronic, Inc.|Lined infusion catheter|

US5693029A|1995-07-10|1997-12-02|World Medical Manufacturing Corporation|Pro-cell intra-cavity therapeutic agent delivery device|

US5746716A|1995-07-10|1998-05-05|Interventional Technologies Inc.|Catheter for injecting fluid medication into an arterial wall|

US5873852A|1995-07-10|1999-02-23|Interventional Technologies|Device for injecting fluid into a wall of a blood vessel|

US5906599A|1995-11-09|1999-05-25|Intermed, Inc.|Device for delivering biological agents|

US5643228A|1995-11-13|1997-07-01|Uresil Corporation|Catheter|

EP0871512A1|1995-12-22|1998-10-21|Localmed, Inc.|Localized intravascular delivery of growth factors for promotion of angiogenesis|

US5713863A|1996-01-11|1998-02-03|Interventional Technologies Inc.|Catheter with fluid medication injectors|

US5833658A|1996-04-29|1998-11-10|Levy; Robert J.|Catheters for the delivery of solutions and suspensions|

US5766152A|1996-08-15|1998-06-16|Cardima, Inc.|Intraluminal delivery of tissue lysing medium|

US5797878A|1996-08-15|1998-08-25|Guidant Corporation|Catheter having optimized balloon taper angle|

US5968068A|1996-09-12|1999-10-19|Baxter International Inc.|Endovascular delivery system|

US5866561A|1997-08-21|1999-02-02|Scimed Life Systems, Inc.|Local delivery of estrogen for angiogenesis|

US5947890A|1997-09-19|1999-09-07|Spencer; Robert H.|Apparatus and improved method for safely dispensing and delivering liquid radiation for intraluminal radiation therapy|

US5908413A|1997-10-03|1999-06-01|Scimed Life Systems, Inc.|Radiopaque catheter and method of manufacture thereof|

US5916195A|1998-02-04|1999-06-29|Argomed Ltd.|Internal catheter|

US5971968A|1999-04-08|1999-10-26|Irvine Biomedical, Inc.|Catheter probe having contrast media delivery means|

US6283947B1|1999-07-13|2001-09-04|Advanced Cardiovascular Systems, Inc.|Local drug delivery injection catheter|US7682647B2|1999-09-03|2010-03-23|Advanced Cardiovascular Systems, Inc.|Thermal treatment of a drug eluting implantable medical device|

US6302875B1|1996-10-11|2001-10-16|Transvascular, Inc.|Catheters and related devices for forming passageways between blood vessels or other anatomical structures|

US6283947B1|1999-07-13|2001-09-04|Advanced Cardiovascular Systems, Inc.|Local drug delivery injection catheter|

US6494862B1|1999-07-13|2002-12-17|Advanced Cardiovascular Systems, Inc.|Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway|

US6790228B2|1999-12-23|2004-09-14|Advanced Cardiovascular Systems, Inc.|Coating for implantable devices and a method of forming the same|

US7807211B2|1999-09-03|2010-10-05|Advanced Cardiovascular Systems, Inc.|Thermal treatment of an implantable medical device|

US20050238686A1|1999-12-23|2005-10-27|Advanced Cardiovascular Systems, Inc.|Coating for implantable devices and a method of forming the same|

US8435550B2|2002-12-16|2013-05-07|Abbot Cardiovascular Systems Inc.|Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device|

US7682648B1|2000-05-31|2010-03-23|Advanced Cardiovascular Systems, Inc.|Methods for forming polymeric coatings on stents|

US6451373B1|2000-08-04|2002-09-17|Advanced Cardiovascular Systems, Inc.|Method of forming a therapeutic coating onto a surface of an implantable prosthesis|

US6953560B1|2000-09-28|2005-10-11|Advanced Cardiovascular Systems, Inc.|Barriers for polymer-coated implantable medical devices and methods for making the same|

US7807210B1|2000-10-31|2010-10-05|Advanced Cardiovascular Systems, Inc.|Hemocompatible polymers on hydrophobic porous polymers|

US6692466B1|2000-12-21|2004-02-17|Advanced Cardiovascular Systems, Inc.|Drug delivery catheter with retractable needle|

US6824559B2|2000-12-22|2004-11-30|Advanced Cardiovascular Systems, Inc.|Ethylene-carboxyl copolymers as drug delivery matrices|

US6599267B1|2000-12-22|2003-07-29|Advanced Cardiovascular Systems, Inc.|Transluminal injection device for intravascular drug delivery|

US7481790B2|2000-12-27|2009-01-27|Advanced Cardiovascular Systems, Inc.|Vessel enlargement by arteriogenic factor delivery|

EP1412013A2|2001-03-30|2004-04-28|Nanopass Ltd.|Inflatable medical device with combination cutting elements and drug delivery conduits|

US6780424B2|2001-03-30|2004-08-24|Charles David Claude|Controlled morphologies in polymer drug for release of drugs from polymer films|

US7056967B2|2001-04-10|2006-06-06|Ciba Specialty Chemicals Corporation|Stabilized medium and high voltage cable insulation composition|

US6712845B2|2001-04-24|2004-03-30|Advanced Cardiovascular Systems, Inc.|Coating for a stent and a method of forming the same|

US6656506B1|2001-05-09|2003-12-02|Advanced Cardiovascular Systems, Inc.|Microparticle coated medical device|

US6743462B1|2001-05-31|2004-06-01|Advanced Cardiovascular Systems, Inc.|Apparatus and method for coating implantable devices|

US6702744B2|2001-06-20|2004-03-09|Advanced Cardiovascular Systems, Inc.|Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery|

US8608661B1|2001-11-30|2013-12-17|Advanced Cardiovascular Systems, Inc.|Method for intravascular delivery of a treatment agent beyond a blood vessel wall|

US6695920B1|2001-06-27|2004-02-24|Advanced Cardiovascular Systems, Inc.|Mandrel for supporting a stent and a method of using the mandrel to coat a stent|

US8741378B1|2001-06-27|2014-06-03|Advanced Cardiovascular Systems, Inc.|Methods of coating an implantable device|

US7682669B1|2001-07-30|2010-03-23|Advanced Cardiovascular Systems, Inc.|Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device|

DE10137102A1|2001-07-30|2003-02-27|Deutsches Krebsforsch|Polyvalent vaccine against diseases caused by papillomaviruses, processes for their production and their use|

US8303651B1|2001-09-07|2012-11-06|Advanced Cardiovascular Systems, Inc.|Polymeric coating for reducing the rate of release of a therapeutic substance from a stent|

US7989018B2|2001-09-17|2011-08-02|Advanced Cardiovascular Systems, Inc.|Fluid treatment of a polymeric coating on an implantable medical device|

US6860867B2|2001-09-20|2005-03-01|The Regents Of The University Of California|Method of interventional surgery|

US6547803B2|2001-09-20|2003-04-15|The Regents Of The University Of California|Microfabricated surgical device for interventional procedures|

US7547294B2|2001-09-20|2009-06-16|The Regents Of The University Of California|Microfabricated surgical device for interventional procedures|

US7223282B1|2001-09-27|2007-05-29|Advanced Cardiovascular Systems, Inc.|Remote activation of an implantable device|

US6808518B2|2001-09-28|2004-10-26|Ethicon, Inc.|Methods and devices for treating diseased blood vessels|

US20030171734A1|2002-01-22|2003-09-11|Endobionics, Inc.|Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia|

US20060189941A1|2002-01-22|2006-08-24|Mercator Medsystems, Inc.|Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation|

US10441747B2|2002-01-22|2019-10-15|Mercator Medsystems, Inc.|Methods and systems for inhibiting vascular inflammation|

US7744584B2|2002-01-22|2010-06-29|Mercator Medsystems, Inc.|Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation|

JP4229621B2|2002-03-05|2009-02-25|修加藤|Chemical injection catheter|

US7919075B1|2002-03-20|2011-04-05|Advanced Cardiovascular Systems, Inc.|Coatings for implantable medical devices|

US20070032853A1|2002-03-27|2007-02-08|Hossainy Syed F|40-O-ethyl-rapamycin coated stent|

US6855136B2|2002-04-03|2005-02-15|Gore Enterprise Holdings, Inc.|Infusion catheter having an atraumatic tip|

US7617005B2|2002-04-08|2009-11-10|Ardian, Inc.|Methods and apparatus for thermally-induced renal neuromodulation|

US20040038303A1|2002-04-08|2004-02-26|Unger Gretchen M.|Biologic modulations with nanoparticles|

US20080213331A1|2002-04-08|2008-09-04|Ardian, Inc.|Methods and devices for renal nerve blocking|

US8150519B2|2002-04-08|2012-04-03|Ardian, Inc.|Methods and apparatus for bilateral renal neuromodulation|

US20070135875A1|2002-04-08|2007-06-14|Ardian, Inc.|Methods and apparatus for thermally-induced renal neuromodulation|

US20070129761A1|2002-04-08|2007-06-07|Ardian, Inc.|Methods for treating heart arrhythmia|

US9636174B2|2002-04-08|2017-05-02|Medtronic Ardian Luxembourg S.A.R.L.|Methods for therapeutic renal neuromodulation|

US20030199852A1|2002-04-23|2003-10-23|Endobionics, Inc.|Attachment joints with polymer encapsulation|

US7033345B2|2002-05-21|2006-04-25|Advanced Cardiovascular Systems, Inc.|Deflectable microimplant delivery system|

US7794743B2|2002-06-21|2010-09-14|Advanced Cardiovascular Systems, Inc.|Polycationic peptide coatings and methods of making the same|

US7033602B1|2002-06-21|2006-04-25|Advanced Cardiovascular Systems, Inc.|Polycationic peptide coatings and methods of coating implantable medical devices|

US8506617B1|2002-06-21|2013-08-13|Advanced Cardiovascular Systems, Inc.|Micronized peptide coated stent|

US7217426B1|2002-06-21|2007-05-15|Advanced Cardiovascular Systems, Inc.|Coatings containing polycationic peptides for cardiovascular therapy|

US7056523B1|2002-06-21|2006-06-06|Advanced Cardiovascular Systems, Inc.|Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine|

US7465298B2|2002-06-28|2008-12-16|Mercator Medsystems, Inc.|Methods and systems for delivering liquid substances to tissues surrounding body lumens|

US7361368B2|2002-06-28|2008-04-22|Advanced Cardiovascular Systems, Inc.|Device and method for combining a treatment agent and a gel|

DE10235689A1|2002-07-31|2004-02-19|Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin|Implant to administer small doses of an active agent directly into the bloodstream at a blood vessel, comprising a base body against the blood vessel wall with micro-injectors through the artery wall|

US6991617B2|2002-08-21|2006-01-31|Hektner Thomas R|Vascular treatment method and device|

US6929621B2|2002-10-02|2005-08-16|Civco Medical Instruments Co., Inc.|Drainage catheter with bifurcating tip|

US6855124B1|2002-10-02|2005-02-15|Advanced Cardiovascular Systems, Inc.|Flexible polymer needle catheter|

US7087263B2|2002-10-09|2006-08-08|Advanced Cardiovascular Systems, Inc.|Rare limiting barriers for implantable medical devices|

US6896965B1|2002-11-12|2005-05-24|Advanced Cardiovascular Systems, Inc.|Rate limiting barriers for implantable devices|

US6982004B1|2002-11-26|2006-01-03|Advanced Cardiovascular Systems, Inc.|Electrostatic loading of drugs on implantable medical devices|

US20040162542A1|2002-12-03|2004-08-19|Endobionics, Inc.|Methods and systems for treating the vasculature with estrogens|

US7776926B1|2002-12-11|2010-08-17|Advanced Cardiovascular Systems, Inc.|Biocompatible coating for implantable medical devices|

US7758880B2|2002-12-11|2010-07-20|Advanced Cardiovascular Systems, Inc.|Biocompatible polyacrylate compositions for medical applications|

US7074276B1|2002-12-12|2006-07-11|Advanced Cardiovascular Systems, Inc.|Clamp mandrel fixture and a method of using the same to minimize coating defects|

US7563483B2|2003-02-26|2009-07-21|Advanced Cardiovascular Systems Inc.|Methods for fabricating a coating for implantable medical devices|

US6926919B1|2003-02-26|2005-08-09|Advanced Cardiovascular Systems, Inc.|Method for fabricating a coating for a medical device|

US7063884B2|2003-02-26|2006-06-20|Advanced Cardiovascular Systems, Inc.|Stent coating|

JP4272905B2|2003-03-06|2009-06-03|修加藤|Chemical injection device|

US7141041B2|2003-03-19|2006-11-28|Mercator Medsystems, Inc.|Catheters having laterally deployable needles|

US8038991B1|2003-04-15|2011-10-18|Abbott Cardiovascular Systems Inc.|High-viscosity hyaluronic acid compositions to treat myocardial conditions|

US7641643B2|2003-04-15|2010-01-05|Abbott Cardiovascular Systems Inc.|Methods and compositions to treat myocardial conditions|

US8821473B2|2003-04-15|2014-09-02|Abbott Cardiovascular Systems Inc.|Methods and compositions to treat myocardial conditions|

US20040213770A1|2003-04-22|2004-10-28|Endobionics, Inc.|Methods and systems for treating ischemic cardiac and other tissues|

JP4289919B2|2003-05-06|2009-07-01|朝日インテック株式会社|Chemical injection device|

US7279174B2|2003-05-08|2007-10-09|Advanced Cardiovascular Systems, Inc.|Stent coatings comprising hydrophilic additives|

US20040236414A1|2003-05-23|2004-11-25|Brar Balbir S.|Devices and methods for treatment of stenotic regions|

US7226473B2|2003-05-23|2007-06-05|Brar Balbir S|Treatment of stenotic regions|

US7285304B1|2003-06-25|2007-10-23|Advanced Cardiovascular Systems, Inc.|Fluid treatment of a polymeric coating on an implantable medical device|

US20050021127A1|2003-07-21|2005-01-27|Kawula Paul John|Porous glass fused onto stent for drug retention|

US7056591B1|2003-07-30|2006-06-06|Advanced Cardiovascular Systems, Inc.|Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same|

US20050027350A1|2003-07-30|2005-02-03|Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin|Endovascular implant for the injection of an active substance into the media of a blood vessel|

US7645474B1|2003-07-31|2010-01-12|Advanced Cardiovascular Systems, Inc.|Method and system of purifying polymers for use with implantable medical devices|

US7785512B1|2003-07-31|2010-08-31|Advanced Cardiovascular Systems, Inc.|Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices|

US7431959B1|2003-07-31|2008-10-07|Advanced Cardiovascular Systems Inc.|Method and system for irradiation of a drug eluting implantable medical device|

US7441513B1|2003-09-26|2008-10-28|Advanced Cardiovascular Systems, Inc.|Plasma-generated coating apparatus for medical devices and a method of coating deposition|

US7198675B2|2003-09-30|2007-04-03|Advanced Cardiovascular Systems|Stent mandrel fixture and method for selectively coating surfaces of a stent|

US7318932B2|2003-09-30|2008-01-15|Advanced Cardiovascular Systems, Inc.|Coatings for drug delivery devices comprising hydrolitically stable adducts of poly and methods for fabricating the same|

US7704544B2|2003-10-07|2010-04-27|Advanced Cardiovascular Systems, Inc.|System and method for coating a tubular implantable medical device|

US7329413B1|2003-11-06|2008-02-12|Advanced Cardiovascular Systems, Inc.|Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof|

US9114198B2|2003-11-19|2015-08-25|Advanced Cardiovascular Systems, Inc.|Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same|

US8192752B2|2003-11-21|2012-06-05|Advanced Cardiovascular Systems, Inc.|Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same|

US7560492B1|2003-11-25|2009-07-14|Advanced Cardiovascular Systems, Inc.|Polysulfone block copolymers as drug-eluting coating material|

US7807722B2|2003-11-26|2010-10-05|Advanced Cardiovascular Systems, Inc.|Biobeneficial coating compositions and methods of making and using thereof|

US20050118344A1|2003-12-01|2005-06-02|Pacetti Stephen D.|Temperature controlled crimping|

US7220816B2|2003-12-16|2007-05-22|Advanced Cardiovascular Systems, Inc.|Biologically absorbable coatings for implantable devices based on poly and methods for fabricating the same|

US7435788B2|2003-12-19|2008-10-14|Advanced Cardiovascular Systems, Inc.|Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents|

US8309112B2|2003-12-24|2012-11-13|Advanced Cardiovascular Systems, Inc.|Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same|

US7273469B1|2003-12-31|2007-09-25|Advanced Cardiovascular Systems, Inc.|Modified needle catheter for directional orientation delivery|

US8685431B2|2004-03-16|2014-04-01|Advanced Cardiovascular Systems, Inc.|Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same|

US8551512B2|2004-03-22|2013-10-08|Advanced Cardiovascular Systems, Inc.|Polyethylene glycol/poly copolymer coated devices including EVEROLIMUS|

US8778014B1|2004-03-31|2014-07-15|Advanced Cardiovascular Systems, Inc.|Coatings for preventing balloon damage to polymer coated stents|

US8293890B2|2004-04-30|2012-10-23|Advanced Cardiovascular Systems, Inc.|Hyaluronic acid based copolymers|

US7820732B2|2004-04-30|2010-10-26|Advanced Cardiovascular Systems, Inc.|Methods for modulating thermal and mechanical properties of coatings on implantable devices|

WO2005112569A2|2004-05-13|2005-12-01|Medtronic Vascular, Inc.|Methods for compounding and delivering a therapeutic agent to the adventitia of a vessel|

JP2007536986A|2004-05-14|2007-12-20|オムニソニックスメディカルテクノロジーズインコーポレイテッド|Ultrasonic probe that can be bent using a balloon|

US7128243B2|2004-05-19|2006-10-31|Fallaha Khalil M|Integrated drip proof stopper system|

US20050265960A1|2004-05-26|2005-12-01|Pacetti Stephen D|Polymers containing poly and agents for use with medical articles and methods of fabricating the same|

US9561309B2|2004-05-27|2017-02-07|Advanced Cardiovascular Systems, Inc.|Antifouling heparin coatings|

US20050271700A1|2004-06-03|2005-12-08|Desnoyer Jessica R|Poly coating composition for implantable devices|

US8636694B2|2004-06-14|2014-01-28|Medtronic, Inc.|Modular medical injection system|

US7563780B1|2004-06-18|2009-07-21|Advanced Cardiovascular Systems, Inc.|Heparin prodrugs and drug delivery stents formed therefrom|

US20050287184A1|2004-06-29|2005-12-29|Hossainy Syed F A|Drug-delivery stent formulations for restenosis and vulnerable plaque|

US7758881B2|2004-06-30|2010-07-20|Advanced Cardiovascular Systems, Inc.|Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device|

US20060002968A1|2004-06-30|2006-01-05|Gordon Stewart|Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders|

US8357391B2|2004-07-30|2013-01-22|Advanced Cardiovascular Systems, Inc.|Coatings for implantable devices comprising polyand diacid linkages|

US7494665B1|2004-07-30|2009-02-24|Advanced Cardiovascular Systems, Inc.|Polymers containing siloxane monomers|

US7648727B2|2004-08-26|2010-01-19|Advanced Cardiovascular Systems, Inc.|Methods for manufacturing a coated stent-balloon assembly|

US7244443B2|2004-08-31|2007-07-17|Advanced Cardiovascular Systems, Inc.|Polymers of fluorinated monomers and hydrophilic monomers|

US8110211B2|2004-09-22|2012-02-07|Advanced Cardiovascular Systems, Inc.|Medicated coatings for implantable medical devices including polyacrylates|

US7166680B2|2004-10-06|2007-01-23|Advanced Cardiovascular Systems, Inc.|Blends of poly polymers|

JP4821947B2|2004-10-19|2011-11-24|朝日インテック株式会社|Chemical injection device|

US8603634B2|2004-10-27|2013-12-10|Abbott Cardiovascular Systems Inc.|End-capped poly copolymers|

US20060089485A1|2004-10-27|2006-04-27|Desnoyer Jessica R|End-capped poly copolymers|

US20060095122A1|2004-10-29|2006-05-04|Advanced Cardiovascular Systems, Inc.|Implantable devices comprising biologically absorbable star polymers and methods for fabricating the same|

US7390497B2|2004-10-29|2008-06-24|Advanced Cardiovascular Systems, Inc.|Poly filler blends for modulation of coating properties|

US7879011B2|2004-11-18|2011-02-01|Silk Road Medical, Inc.|Endoluminal delivery of anesthesia|

US7214759B2|2004-11-24|2007-05-08|Advanced Cardiovascular Systems, Inc.|Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same|

US7588642B1|2004-11-29|2009-09-15|Advanced Cardiovascular Systems, Inc.|Abluminal stent coating apparatus and method using a brush assembly|

US8609123B2|2004-11-29|2013-12-17|Advanced Cardiovascular Systems, Inc.|Derivatized poly as a biobeneficial coating|

US7892592B1|2004-11-30|2011-02-22|Advanced Cardiovascular Systems, Inc.|Coating abluminal surfaces of stents and other implantable medical devices|

US20060115449A1|2004-11-30|2006-06-01|Advanced Cardiovascular Systems, Inc.|Bioabsorbable, biobeneficial, tyrosine-based polymers for use in drug eluting stent coatings|

US8262605B2|2004-12-09|2012-09-11|Ams Research Corporation|Needleless delivery systems|

US7803168B2|2004-12-09|2010-09-28|The Foundry, Llc|Aortic valve repair|

US7604818B2|2004-12-22|2009-10-20|Advanced Cardiovascular Systems, Inc.|Polymers of fluorinated monomers and hydrocarbon monomers|

US7419504B2|2004-12-27|2008-09-02|Advanced Cardiovascular Systems, Inc.|Poly block copolymers|

US7303572B2|2004-12-30|2007-12-04|Cook Incorporated|Catheter assembly with plaque cutting balloon|

US8007775B2|2004-12-30|2011-08-30|Advanced Cardiovascular Systems, Inc.|Polymers containing poly and agents for use with medical articles and methods of fabricating the same|

US20060178685A1|2004-12-30|2006-08-10|Cook Incorporated|Balloon expandable plaque cutting device|

US7202325B2|2005-01-14|2007-04-10|Advanced Cardiovascular Systems, Inc.|Poly and agents for use with medical articles|

US20060224118A1|2005-03-31|2006-10-05|Morris Mary M|Medical fluid delivery system|

US8303972B2|2005-04-19|2012-11-06|Advanced Cardiovascular Systems, Inc.|Hydrogel bioscaffoldings and biomedical device coatings|

US8828433B2|2005-04-19|2014-09-09|Advanced Cardiovascular Systems, Inc.|Hydrogel bioscaffoldings and biomedical device coatings|

US8187621B2|2005-04-19|2012-05-29|Advanced Cardiovascular Systems, Inc.|Methods and compositions for treating post-myocardial infarction damage|

US20080125745A1|2005-04-19|2008-05-29|Shubhayu Basu|Methods and compositions for treating post-cardial infarction damage|

US9539410B2|2005-04-19|2017-01-10|Abbott Cardiovascular Systems Inc.|Methods and compositions for treating post-cardial infarction damage|

US7795467B1|2005-04-26|2010-09-14|Advanced Cardiovascular Systems, Inc.|Bioabsorbable, biobeneficial polyurethanes for use in medical devices|

US8778375B2|2005-04-29|2014-07-15|Advanced Cardiovascular Systems, Inc.|Amorphous poly coating|

US10076641B2|2005-05-11|2018-09-18|The Spectranetics Corporation|Methods and systems for delivering substances into luminal walls|

WO2006133193A1|2005-06-07|2006-12-14|American Medical Systems Research Corporation|Injection guidance system and method|

WO2007002304A2|2005-06-22|2007-01-04|Vnus Medical Technologies, Inc.|Methods and apparatus for introducing tumescent fluid to body tissue|

US7823533B2|2005-06-30|2010-11-02|Advanced Cardiovascular Systems, Inc.|Stent fixture and method for reducing coating defects|

US8021676B2|2005-07-08|2011-09-20|Advanced Cardiovascular Systems, Inc.|Functionalized chemically inert polymers for coatings|

US7785647B2|2005-07-25|2010-08-31|Advanced Cardiovascular Systems, Inc.|Methods of providing antioxidants to a drug containing product|

US7735449B1|2005-07-28|2010-06-15|Advanced Cardiovascular Systems, Inc.|Stent fixture having rounded support structures and method for use thereof|

US7919583B2|2005-08-08|2011-04-05|Discovery Genomics, Inc.|Integration-site directed vector systems|

JP4868387B2|2005-09-21|2012-02-01|朝日インテック株式会社|Chemical injection device|

US7708753B2|2005-09-27|2010-05-04|Cook Incorporated|Balloon catheter with extendable dilation wire|

US7867169B2|2005-12-02|2011-01-11|Abbott Cardiovascular Systems Inc.|Echogenic needle catheter configured to produce an improved ultrasound image|

US8303505B2|2005-12-02|2012-11-06|Abbott Cardiovascular Systems Inc.|Methods and apparatuses for image guided medical procedures|

US20070128246A1|2005-12-06|2007-06-07|Hossainy Syed F A|Solventless method for forming a coating|

US20070135909A1|2005-12-08|2007-06-14|Desnoyer Jessica R|Adhesion polymers to improve stent retention|

US7976891B1|2005-12-16|2011-07-12|Advanced Cardiovascular Systems, Inc.|Abluminal stent coating apparatus and method of using focused acoustic energy|

US7867547B2|2005-12-19|2011-01-11|Advanced Cardiovascular Systems, Inc.|Selectively coating luminal surfaces of stents|

US7620451B2|2005-12-29|2009-11-17|Ardian, Inc.|Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach|

US20070196428A1|2006-02-17|2007-08-23|Thierry Glauser|Nitric oxide generating medical devices|

US20080077165A1|2006-02-24|2008-03-27|National University Of Ireland, Galway|Minimally Invasive Intravascular Treatment Device|

ES2335520T3|2006-02-24|2010-03-29|National University Of Ireland, Galway|MINIMALLY INVASIVE INTRAVASCULAR TREATMENT DEVICE.|

US20080077164A1|2006-02-24|2008-03-27|National University Of Ireland, Galway|Minimally Invasive Intravascular Treatment Device|

US7601383B2|2006-02-28|2009-10-13|Advanced Cardiovascular Systems, Inc.|Coating construct containing poly |

US7713637B2|2006-03-03|2010-05-11|Advanced Cardiovascular Systems, Inc.|Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer|

US20070231363A1|2006-03-29|2007-10-04|Yung-Ming Chen|Coatings formed from stimulus-sensitive material|

US20070259101A1|2006-05-02|2007-11-08|Kleiner Lothar W|Microporous coating on medical devices|

US8304012B2|2006-05-04|2012-11-06|Advanced Cardiovascular Systems, Inc.|Method for drying a stent|

US8003156B2|2006-05-04|2011-08-23|Advanced Cardiovascular Systems, Inc.|Rotatable support elements for stents|

US7985441B1|2006-05-04|2011-07-26|Yiwen Tang|Purification of polymers for coating applications|

US7794402B2|2006-05-15|2010-09-14|Advanced Cardiovascular Systems, Inc.|Echogenic needle catheter configured to produce an improved ultrasound image|

US20070269385A1|2006-05-18|2007-11-22|Mercator Medsystems, Inc|Devices, methods, and systems for delivering therapeutic agents for the treatment of sinusitis, rhinitis, and other disorders|

US20080004596A1|2006-05-25|2008-01-03|Palo Alto Institute|Delivery of agents by microneedle catheter|

US7775178B2|2006-05-26|2010-08-17|Advanced Cardiovascular Systems, Inc.|Stent coating apparatus and method|

US8568764B2|2006-05-31|2013-10-29|Advanced Cardiovascular Systems, Inc.|Methods of forming coating layers for medical devices utilizing flash vaporization|

US9561351B2|2006-05-31|2017-02-07|Advanced Cardiovascular Systems, Inc.|Drug delivery spiral coil construct|

US8703167B2|2006-06-05|2014-04-22|Advanced Cardiovascular Systems, Inc.|Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug|

US20080124372A1|2006-06-06|2008-05-29|Hossainy Syed F A|Morphology profiles for control of agent release rates from polymer matrices|

US8778376B2|2006-06-09|2014-07-15|Advanced Cardiovascular Systems, Inc.|Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating|

US20070286882A1|2006-06-09|2007-12-13|Yiwen Tang|Solvent systems for coating medical devices|

US8603530B2|2006-06-14|2013-12-10|Abbott Cardiovascular Systems Inc.|Nanoshell therapy|

US8114150B2|2006-06-14|2012-02-14|Advanced Cardiovascular Systems, Inc.|RGD peptide attached to bioabsorbable stents|

US8048448B2|2006-06-15|2011-11-01|Abbott Cardiovascular Systems Inc.|Nanoshells for drug delivery|

US8017237B2|2006-06-23|2011-09-13|Abbott Cardiovascular Systems, Inc.|Nanoshells on polymers|

US9192697B2|2007-07-03|2015-11-24|Hemoteq Ag|Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis|

US9028859B2|2006-07-07|2015-05-12|Advanced Cardiovascular Systems, Inc.|Phase-separated block copolymer coatings for implantable medical devices|

US8685430B1|2006-07-14|2014-04-01|Abbott Cardiovascular Systems Inc.|Tailored aliphatic polyesters for stent coatings|

US7732190B2|2006-07-31|2010-06-08|Advanced Cardiovascular Systems, Inc.|Modified two-component gelation systems, methods of use and methods of manufacture|

EP2068975A4|2006-08-08|2013-10-30|Peak Biosciences Inc|Catheter and array for anticancer therapy|

US8703169B1|2006-08-15|2014-04-22|Abbott Cardiovascular Systems Inc.|Implantable device having a coating comprising carrageenan and a biostable polymer|

US9242005B1|2006-08-21|2016-01-26|Abbott Cardiovascular Systems Inc.|Pro-healing agent formulation compositions, methods and treatments|

US8834493B2|2006-10-20|2014-09-16|St. Jude Medical, Cardiology Division, Inc.|Device and method for vascular closure|

US8906044B2|2006-10-20|2014-12-09|St. Jude Medical, Cardiology Division, Inc.|Knot pusher device|

US9107656B2|2006-10-20|2015-08-18|St. Jude Medical, Cardiovascular Division, Inc.|Internal suturing device leg suspension system and method of use|

US8080035B2|2006-10-20|2011-12-20|St. Jude Medical, Cardiology Division, Inc.|Suture attachment device|

US8834494B2|2006-10-20|2014-09-16|St. Jude Medical, Cardiology Division, Inc.|Method and device for automated needle deployment|

US8741326B2|2006-11-17|2014-06-03|Abbott Cardiovascular Systems Inc.|Modified two-component gelation systems, methods of use and methods of manufacture|

US9005672B2|2006-11-17|2015-04-14|Abbott Cardiovascular Systems Inc.|Methods of modifying myocardial infarction expansion|

US8192760B2|2006-12-04|2012-06-05|Abbott Cardiovascular Systems Inc.|Methods and compositions for treating tissue using silk proteins|

US8597673B2|2006-12-13|2013-12-03|Advanced Cardiovascular Systems, Inc.|Coating of fast absorption or dissolution|

EP2136853B1|2007-01-21|2013-04-10|Hemoteq AG|Medical product for treating stenosis of body passages and for preventing threatening restenosis|

US20080228139A1|2007-02-06|2008-09-18|Cook Incorporated|Angioplasty Balloon With Concealed Wires|

US8323307B2|2007-02-13|2012-12-04|Cook Medical Technologies Llc|Balloon catheter with dilating elements|

US20080200377A1|2007-02-16|2008-08-21|Trollsas Mikael O|Polymer particles|

US20110135569A1|2007-03-20|2011-06-09|Peak Biosciences Inc.|Method for therapeutic administration of radionucleosides|

WO2008140808A1|2007-05-10|2008-11-20|Peak Biosciences, Inc.|Methods for administration of radiotherapeutic agents|

US8147769B1|2007-05-16|2012-04-03|Abbott Cardiovascular Systems Inc.|Stent and delivery system with reduced chemical degradation|

US9056155B1|2007-05-29|2015-06-16|Abbott Cardiovascular Systems Inc.|Coatings having an elastic primer layer|

US20080300610A1|2007-05-31|2008-12-04|Cook Incorporated|Device for treating hardened lesions and method of use thereof|

US8048441B2|2007-06-25|2011-11-01|Abbott Cardiovascular Systems, Inc.|Nanobead releasing medical devices|

US8109904B1|2007-06-25|2012-02-07|Abbott Cardiovascular Systems Inc.|Drug delivery medical devices|

US8007470B2|2007-07-10|2011-08-30|Cook Medical Technologies Llc|Minimally invasive medical device and method for delivery of therapeutic or diagnostic agents into a vessel wall|

US20090041845A1|2007-08-08|2009-02-12|Lothar Walter Kleiner|Implantable medical devices having thin absorbable coatings|

US20090171284A1|2007-12-27|2009-07-02|Cook Incorporated|Dilation system|

CA2711990A1|2008-01-31|2009-08-06|F. Nicholas Franano|Medical device|

EP2254645B1|2008-03-13|2014-04-16|Cook Medical Technologies LLC|Method of forming a cutting balloon with connector and dilation element|

US8486022B2|2008-07-03|2013-07-16|Abbott Cardiovascular Systems Inc.|Needle catheter with an angled distal tip lumen|

US20100010521A1|2008-07-10|2010-01-14|Cook Incorporated|Cutting balloon with movable member|

US20100105140A1|2008-07-16|2010-04-29|Fahrenkrug Scott C|Plaice dna transposon system|

WO2010011930A2|2008-07-24|2010-01-28|Boston Scientific Scimed, Inc.|Various catheter devices for myocardial injections or other uses|

US20100191168A1|2009-01-29|2010-07-29|Trustees Of Tufts College|Endovascular cerebrospinal fluid shunt|

RU2011142447A|2009-04-22|2013-05-27|Меркатор МедСистемс, Инк.|USE OF GUANETHIDINE FOR THE TREATMENT OF HYPERTENSION BY LOCAL VASCULAR DELIVERY|

US20100292641A1|2009-05-15|2010-11-18|Bandula Wijay|Targeted drug delivery device and method|

WO2010137705A1|2009-05-29|2010-12-02|オリンパスメディカルシステムズ株式会社|Capsule type medical device|

JP2012532670A|2009-07-10|2012-12-20|ボストンサイエンティフィックサイムド，インコーポレイテッド|Use of nanocrystals for drug delivery balloons|

US10080821B2|2009-07-17|2018-09-25|Boston Scientific Scimed, Inc.|Nucleation of drug delivery balloons to provide improved crystal size and density|

US8348987B2|2009-12-22|2013-01-08|Cook Medical Technologies Llc|Balloon with scoring member|

US8685433B2|2010-03-31|2014-04-01|Abbott Cardiovascular Systems Inc.|Absorbable coating for implantable device|

EP2380604A1|2010-04-19|2011-10-26|InnoRa Gmbh|Improved coating formulations for scoring or cutting balloon catheters|

US8889211B2|2010-09-02|2014-11-18|Boston Scientific Scimed, Inc.|Coating process for drug delivery balloons using heat-induced rewrap memory|

US9545323B2|2010-11-16|2017-01-17|W. L. Gore & Associates, Inc.|Fenestration devices, systems, and methods|

WO2012083155A2|2010-12-16|2012-06-21|Ams Research Corporation|Micro-needle bladder balloon|

CN103517731B|2011-04-08|2016-08-31|柯惠有限合伙公司|For removing iontophoresis formula drug delivery system and the method for renal sympathetic nerve and iontophoresis formula drug delivery|

US20120259216A1|2011-04-08|2012-10-11|Gerrans Lawrence J|Balloon catheter with drug delivery probe|

US9237925B2|2011-04-22|2016-01-19|Ablative Solutions, Inc.|Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation|

US8663190B2|2011-04-22|2014-03-04|Ablative Solutions, Inc.|Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation|

WO2013022458A1|2011-08-05|2013-02-14|Boston Scientific Scimed, Inc.|Methods of converting amorphous drug substance into crystalline form|

US9278196B2|2011-08-24|2016-03-08|Ablative Solutions, Inc.|Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation|

US20130053792A1|2011-08-24|2013-02-28|Ablative Solutions, Inc.|Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation|

US9056185B2|2011-08-24|2015-06-16|Ablative Solutions, Inc.|Expandable catheter system for fluid injection into and deep to the wall of a blood vessel|

US9056152B2|2011-08-25|2015-06-16|Boston Scientific Scimed, Inc.|Medical device with crystalline drug coating|

EP2768514B8|2011-10-19|2019-06-19|Mercator Medsystems, Inc.|Localized modulation of tissues and cells to enhance therapeutic effects including renal denervation|

US10736656B2|2012-10-29|2020-08-11|Ablative Solutions|Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures|

US9554849B2|2012-10-29|2017-01-31|Ablative Solutions, Inc.|Transvascular method of treating hypertension|

US9301795B2|2012-10-29|2016-04-05|Ablative Solutions, Inc.|Transvascular catheter for extravascular delivery|

US10226278B2|2012-10-29|2019-03-12|Ablative Solutions, Inc.|Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures|

US10881458B2|2012-10-29|2021-01-05|Ablative Solutions, Inc.|Peri-vascular tissue ablation catheters|

US10945787B2|2012-10-29|2021-03-16|Ablative Solutions, Inc.|Peri-vascular tissue ablation catheters|

US9526827B2|2012-10-29|2016-12-27|Ablative Solutions, Inc.|Peri-vascular tissue ablation catheter with support structures|

US10433821B2|2013-01-08|2019-10-08|Sanovas Intellectual Property, Llc|Precision directed medical instruments|

US10517666B2|2013-10-25|2019-12-31|Ablative Solutions, Inc.|Apparatus for effective ablation and nerve sensing associated with denervation|

US9931046B2|2013-10-25|2018-04-03|Ablative Solutions, Inc.|Intravascular catheter with peri-vascular nerve activity sensors|

US9949652B2|2013-10-25|2018-04-24|Ablative Solutions, Inc.|Apparatus for effective ablation and nerve sensing associated with denervation|

US10286190B2|2013-12-11|2019-05-14|Cook Medical Technologies Llc|Balloon catheter with dynamic vessel engaging member|

US9737696B2|2014-01-15|2017-08-22|Tufts Medical Center, Inc.|Endovascular cerebrospinal fluid shunt|

EP2898920B1|2014-01-24|2018-06-06|Cook Medical Technologies LLC|Articulating balloon catheter|

EP3151901A4|2014-06-03|2018-02-21|Pigott, John, P.|Intravascular catheter with drug delivery system|

ES2828972T3|2014-06-16|2021-05-28|Venturemed Group Inc|Intravascular catheter having an expandable incision portion and drug delivery mechanism|

WO2016070147A1|2014-10-31|2016-05-06|Cerevasc, Llc|Methods and systems for treating hydrocephalus|

JP6989597B2|2016-09-22|2022-01-05|マーケイターメドシステムズ，インコーポレイテッド|Treatment of restenosis with temsirolimus|

CA3064780A1|2017-05-26|2018-11-29|Mercator Medsystems, Inc.|Combination therapy for treatment of restenosis|

US11116561B2|2018-01-24|2021-09-14|Medtronic Ardian Luxembourg S.A.R.L.|Devices, agents, and associated methods for selective modulation of renal nerves|

US10849685B2|2018-07-18|2020-12-01|Ablative Solutions, Inc.|Peri-vascular tissue access catheter with locking handle|

WO2021133966A1|2019-12-24|2021-07-01|Encompass Vascular, Inc.|Medical devices for fluid delivery|

法律状态:
2001-02-27| AS| Assignment|Owner name: ADVANCED CARDIOVASCULAR SYSTEMS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GUIDANT CORPORATION;REEL/FRAME:011614/0498 Effective date: 20000510 |

2004-01-22| STCF| Information on status: patent grant|Free format text: PATENTED CASE |

2007-06-21| FPAY| Fee payment|Year of fee payment: 4 |

2011-07-21| FPAY| Fee payment|Year of fee payment: 8 |

2015-07-28| FPAY| Fee payment|Year of fee payment: 12 |

优先权:

申请号 | 申请日 | 专利标题

US09/352,628|US6283947B1|1999-07-13|1999-07-13|Local drug delivery injection catheter|

US09/794,791|US6689099B2|1999-07-13|2001-02-27|Local drug delivery injection catheter|US09/794,791| US6689099B2|1999-07-13|2001-02-27|Local drug delivery injection catheter|

[返回顶部]